secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-11-10T21:30:20+00:00
Accession:  0001156039-26-000074
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Elevance Health reaffirms 2026 EPS guidance of at least $22.00 and adjusted EPS of at least $29.00
--------------------------------------------------------------------------------

- Elevance Health reaffirmed full-year 2026 shareholders' earnings guidance of at least $22.00 per diluted share.
- Guidance includes approximately $7.00 per diluted share of net unfavorable items; adjusted earnings guidance is at least $29.00.
- The company reaffirmed 2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points.
- Officers expect to speak with investors and analysts this week and cited no other adjustment items beyond Q3 2026 earnings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/0001156039-26-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/elv-20261110.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer